Secondary renal Fanconi syndrome caused by valproate therapy

Pediatric Nephrology

Volumn 20, Issue 6, 2005, Pages 814-817

  Watanabe, Toru ^a   Yoshikawa, Hideto ^b   Yamazaki, Sawako ^a   Abe, Yuki ^a   Abe, Tokinari ^a  

^a NIIGATA CITY GENERAL HOSPITAL   (Japan)

^b MIYAGI CHILDREN S HOSPITAL   (Japan)

Author keywords

Epilepsy; Kidney disease; Severe disability; Side effect; Tubulointerstitial nephritis; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; BETA 2 MICROGLOBULIN; CLOBAZAM; CLONAZEPAM; CREATININE; DIAZEPAM; ELECTROLYTE; PHOSPHATE; URIC ACID; VALPROIC ACID; ZONISAMIDE;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ADOLESCENT; AGE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DATA ANALYSIS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ELECTROLYTE BLOOD LEVEL; EPILEPSY; FANCONI RENOTUBULAR SYNDROME; FEMALE; GLUCOSURIA; HUMAN; HYPERCHLOREMIA; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; HYPOPHOSPHATEMIA; HYPOURICEMIA; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY TUBULE CELL; MALE; METABOLIC ACIDOSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RISK FACTOR; TREATMENT OUTCOME; TUBE FEEDING; URIC ACID BLOOD LEVEL; URINALYSIS;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; FANCONI SYNDROME; FEMALE; HUMANS; KIDNEY DISEASES; MALE; NEPHRITIS, INTERSTITIAL; VALPROIC ACID;

EID: 18644386727     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1827-7     Document Type: Article

References (24)

1. Dreifuss FE, Langer DH (1988) Side effects of valproate. Am J Med 84 [Suppl 1A]:34-41
2. Lenoir GR, Pèrignon JL, Gubler MC, Broyer M (1981) Valproic acid: a possible cause of proximal tubular renal syndrome. J Pediatr 98:503-504
3. Lande MB, Kim MS, Bartlett C, Guay-Woodford LM (1993) Reversible Fanconi syndrome associated with valproate therapy. J Pediatr 123:320-322
4. Arita K, Kita T, Maeyama M, Adachi K (1996) Fanconi syndrome during valproate therapy (in Japanese). Shonika Rinsho 49:120-124
5. Yoshikawa H, Watanabe T, Abe T (2002) Fanconi syndrome caused by sodium valproate: Report of three severely disabled children. Eur J Paediatr Neurol 6:165-167 12363104
6. Zaki EL, Springate JE (2002) Renal injury from valploic acid: Case report and literature review. Pediatr Neurol 27:318-319
7. Smith GC, Balfe JW, Kooh SW (1995) Anticonvulsants as a cause of Fanconi syndrome. Nephrol Dial Transplant 10:543-545
8. Lin CY, Chiang H (1988) Sodium-valproate-induced interstitial nephritis. Nephron 48:43-46
9. Yoshiya K, Nakazawa S, Yoshioka M, Yoshikawa N (1994) Tobulo-interstitial nephritis caused by sodium valproate (in Japanese). Shonika Shinryo 57:285-288
10. Hawkins E, Brewer E (1993) Renal toxicity induced by valproic acid (Depakene). Pediatr Pathol 13:863-868
11. Fukuda Y, Watanabe H, Ohtomo Y, Yabuta K (1996) Immunologically mediated chronic tubulo-interstitial nephritis caused by valproate therapy. Nephron 72:328-329
12. Yoshikawa H, Watanabe T, Abe T (2002) Tubulo-interstitial nephritis caused by sodium valproate. Brain Dev 24:102-105
13. Foreman JW (2004) Cystinosis and Fanconi syndrome. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, pp 789-806
14. Brodehl J (1992) The Fanconi syndrome. In: Edelmann CM Jr (eds) Pediatric kidney disease. Little Brown, Boston, pp 1841-1869
15. Novo MLP, Izumi T, Yokota K, Fukuyama Y (1993) Urinary excretion of N-acetyl-β-glucosaminidase and β-galactosidase by patients with epilepsy. Brain Dev 15:157-160
16. Korinthenberg R, Wehrle L, Zimmerhackl LB (1994) Renal tubular dysfunction following treatment with anti-epileptic drugs. Eur J Pediatr 153:855-858
17. Altunbaşak Ş, Yildizdaş D, Anarat A, Burgut HR (2001) Renal tubular dysfunction in epileptic children on valproic acid therapy. Pediatr Nephrol 16:256-259
18. Niaudet P, Rötig A (1997) The kidney in mitochondrial cytopaties. Kidney Int 51:1000-1007
19. Anderson GD (2002) Children versus adults: Pharmacokinetic and adverse-effect differences. Epilepsia 43 [Suppl 3]:53-59
20. Igarashi N, Sato T, Kyouya S (1990) Secondary carnitine deficiency in handicapped patients receiving valproic acid and/or elemental diet. Acta Paediatr Jpn 32:139-145
21. Feller AG, Rudman D, Erve PR, Johnson RC, Boswell J, Jackson DL, Mattson DE (1987) Subnormal concentrations of serum selenium and plasma carnitine in chronically tube-fed patients. Am J Clin Nutr 45:476-483
22. Tanaka S, Miki T, Hsieh ST, Kim JI, Yasumoto T, Taniguchi T, Ishikawa Y, Yokoyama M (2003) A case of severe hyperlipidemia caused by long-term tube feedings. J Atheroscler Thromb 10:321-324
23. Ohtani Y, Endo F, Matsuda I (1982) Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 101:782-785
24. Matsuda I, Ohtani Y, Ninomiya N (1986) Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy. J Pediatr 109:131-134